Choi KH - Search Results

1

Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.

Kim Y, Yun HJ, Choi KH, Kim CW, Lee JH, Weicker R, Kim SM, Park KC. Kim Y, et al. Among authors: choi kh. Int J Mol Sci. 2023 Nov 16;24(22):16413. doi: 10.3390/ijms242216413. Int J Mol Sci. 2023. PMID: 38003602 Free PMC article.

2

Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis.

Lim JH, Choi KH, Kim SY, Park CS, Kim SM, Park KC. Lim JH, et al. Among authors: choi kh. Int J Mol Sci. 2020 Oct 10;21(20):7469. doi: 10.3390/ijms21207469. Int J Mol Sci. 2020. PMID: 33050525 Free PMC article.

3

Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma.

Lim JH, Park K, Choi KH, Kim CW, Lee JH, Weicker R, Pan CH, Kim SM, Park KC. Lim JH, et al. Among authors: choi kh. Int J Mol Sci. 2022 Jul 19;23(14):7971. doi: 10.3390/ijms23147971. Int J Mol Sci. 2022. PMID: 35887321 Free PMC article.

4

Potential Therapeutic Agents against Paclitaxel-And Sorafenib-Resistant Papillary Thyroid Carcinoma.

Kim SM, Park K, Lim JH, Yun HJ, Kim SY, Choi KH, Kim CW, Lee JH, Weicker R, Pan CH, Park KC. Kim SM, et al. Among authors: choi kh. Int J Mol Sci. 2022 Sep 8;23(18):10378. doi: 10.3390/ijms231810378. Int J Mol Sci. 2022. PMID: 36142303 Free PMC article.

5

Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer.

Choi KH, Jeon JY, Lee YE, Kim SW, Kim SY, Yun YJ, Park KC. Choi KH, et al. Transl Oncol. 2019 Feb;12(2):381-388. doi: 10.1016/j.tranon.2018.11.007. Epub 2018 Dec 3. Transl Oncol. 2019. PMID: 30522045 Free PMC article.

6

Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.

Na JC, Kim JH, Kim SY, Gu YR, Jun DY, Lee HH, Yoon YE, Choi KH, Hong SJ, Han WK. Na JC, et al. Among authors: choi kh. Investig Clin Urol. 2020 Mar;61(2):216-223. doi: 10.4111/icu.2020.61.2.216. Epub 2020 Feb 3. Investig Clin Urol. 2020. PMID: 32158973 Free PMC article.

7

Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy.

Choi KH, Lee SR, Hong YK, Park DS. Choi KH, et al. Asian J Androl. 2018 May-Jun;20(3):270-275. doi: 10.4103/aja.aja_56_17. Asian J Androl. 2018. PMID: 29271399 Free PMC article.

8

Mitochondrial Sirt3 supports cell proliferation by regulating glutamine-dependent oxidation in renal cell carcinoma.

Choi J, Koh E, Lee YS, Lee HW, Kang HG, Yoon YE, Han WK, Choi KH, Kim KS. Choi J, et al. Among authors: choi kh. Biochem Biophys Res Commun. 2016 Jun 3;474(3):547-553. doi: 10.1016/j.bbrc.2016.04.117. Epub 2016 Apr 23. Biochem Biophys Res Commun. 2016. PMID: 27114304

9

Usefulness of the diameter-axial-polar nephrometry score for predicting perioperative parameters in robotic partial nephrectomy.

Yoon YE, Choi KH, Lee KS, Kim KH, Rha KH, Choi YD, Han WK. Yoon YE, et al. Among authors: choi yd, choi kh. World J Urol. 2015 Jun;33(6):841-5. doi: 10.1007/s00345-014-1372-8. Epub 2014 Aug 20. World J Urol. 2015. PMID: 25138578

10

Sorafenib treatment for recurrent stage T1 bilateral renal cell carcinoma in patients with Von Hippel- Lindau disease: A case report and literature review.

Choi KH, Yu YD, Kang MH, Park DS. Choi KH, et al. Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E651-3. doi: 10.5489/cuaj.2863. Epub 2015 Sep 9. Can Urol Assoc J. 2015. PMID: 26425233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,011 results

Search Page

Filters